M. Kelley et Da. Vessey, CHARACTERIZATION OF THE ACYL-COA-AMINO ACID N-ACYLTRANSFERASES FROM PRIMATE LIVER-MITOCHONDRIA, Journal of biochemical toxicology, 9(3), 1994, pp. 153-158
The acyl-CoA:amino acid N-acyltransferases were partially purified fro
m human liver mitochondria. The aralkyl transferase (ArAlk) had glycin
e conjugating activity toward the following compounds: benzoyl-CoA > b
utyryl-CoA, salicylyl-CoA > heptanoyl-CoA, indoleacetyl-CoA. Its kinet
ic properties and responses to salt were very similar to those of bovi
ne ArAlk. Further, its molecular weight was found to be similar to tha
t of the bovine enzyme, in contrast to reports from other laboratories
. Thus, it was concluded that the human and bovine ArAlk are not signi
ficantly different. The human arylacetyl transferase (AAc) had glutami
ne conjugating activity toward phenylacetyl-CoA, but only 3-5% as much
activity toward indoleacetyl-CoA or 1-naphtylacetyl-CoA, respectively
. While this was similar to the bovine AAc, the two forms differed in
several respects. First, the human liver AAc was insensitive to salts.
Second, glycination of phenylacetyl-CoA by human AAc could only be de
tected at a high concentration of glycine (50 mM), and the rates were
<2% of the rate of glutamination. In contrast, glycine conjugation pre
dominates with bovine AAc. Kinetic analysis of the glutamination of ph
enylacetyl-CoA by human AAc revealed a K(D) for phenylacetyl-CoA of 14
muM and a K(m) for glutamine of 120 mM. These values indicate that th
e human AAc is not more efficient at glutamination than the AAc from b
ovine liver. An AAc was purified from rhesus monkey liver and found to
have similar kinetic constants to the human form. This indicates that
nonprimate enzymes do not have a defect in glutamine conjugation. Rat
her, it is the primate forms that are defective in that they have lost
glycine conjugation, not increased the efficiency of glutamine conjug
ation.